A phase II study of gefitinib in patients with advanced thyroid cancer.
Pennell NA, Daniels GH, Haddad RI, Ross DS, Evans T, Wirth LJ, Fidias PH, Temel JS, Gurubhagavatula S, Heist RS, Clark JR, Lynch TJ.
Pennell NA, et al. Among authors: ross ds.
Thyroid. 2008 Mar;18(3):317-23. doi: 10.1089/thy.2007.0120.
Thyroid. 2008.
PMID: 17985985
Clinical Trial.